Sun Pharma shares fall as Q2 profit plunges 36%, impacting brokerages’ target prices despite their bullish outlook.
Recent Posts
- Sun Pharma shares fall: Q2 profit plunges 36%
- Macular Degeneration Drug Approval: Proven Steps to Success
- Dr Kenneth Pettine and the Importance of Knowledge Exchange in Orthopedic Science
- Expired Covid-era approvals: Are they the worst mistake?
- Vamorolone South Korea approval: A Smart Move for Nxera
Popular Posts
| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 | ||||||


